AmerisourceBergen Corporation (ABC) stock: Winston Score and insider trades
AmerisourceBergen, now operating under the name Cencora, is one of the largest pharmaceutical distribution companies in the world. It buys medicines and healthcare products from drug manufacturers and delivers them to pharmacies, hospitals, and doctors' offices across the United States and internationally. It serves as a critical middleman in the healthcare supply chain, handling billions of dollars worth of drugs each year. The company makes money by purchasing pharmaceuticals in bulk and selling them to healthcare providers at a small markup, which explains its very thin margins on enormous revenue. It operates primarily in the U.S. but has a growing international presence, especially after acquiring Alliance Healthcare. Its massive scale and established relationships with manufacturers and customers create a strong competitive position that is difficult for newcomers to replicate. Key growth drivers include specialty drug distribution and international expansion, while ongoing opioid-related litigation remains a notable risk.
Winston Score: 52 out of 100, Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (12/30)
- Growth: Good (13/20)
- Cash Flow: Strong (7/10)
- Stability: Mixed (3/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: $179.98
Market Cap: $36.1B
Sector: Healthcare
Industry: Medical - Distribution
Exchange: New York Stock Exchange
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-14.


